Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

A comparison of cancer statistics in New Zealand and Australia: 1996-2007.

Waldon J, Lamb DS, Delahunt B, Nacey JN, Dady PJ, Johnson CA, Hall AG, Bethwaite PB, Weinstein P.

N Z Med J. 2014 Aug 15;127(1400):20-9.

PMID:
25145364
2.

Patterns of failure after iodine-125 seed implantation for prostate cancer.

Lamb DS, Greig L, Russell GL, Nacey JN, Broome K, Studd R, Delahunt B, Iupati D, Jain M, Rooney C, Murray J, Lamb PJ, Bethwaite PB.

Radiother Oncol. 2014 Jul;112(1):68-71. doi: 10.1016/j.radonc.2014.07.006. Epub 2014 Jul 28.

PMID:
25082097
3.

Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.

Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M, Samaratunga H, Srigley JR.

Am J Surg Pathol. 2011 Aug;35(8):1134-9. doi: 10.1097/PAS.0b013e318220697f.

PMID:
21716085
4.

Re: Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma: T. Klatte, C. Anterasian, J. W. Said, M. de Martino, F. F. Kabbinavar, A. S. Belldegrun and A. J. Pantuck J Urol 2010; 183: 2143-2147.

Delahunt B, Bethwaite PB, Miller RJ, Sika-Paotonu D, Srigley JR.

J Urol. 2011 Jan;185(1):356-7; author reply 357-8. doi: 10.1016/j.juro.2010.08.045. Epub 2010 Nov 20. No abstract available.

PMID:
21094961
5.

Parameters of perineural invasion in radical prostatectomy specimens lack prognostic significance.

Merrilees AD, Bethwaite PB, Russell GL, Robinson RG, Delahunt B.

Mod Pathol. 2008 Sep;21(9):1095-100. doi: 10.1038/modpathol.2008.81. Epub 2008 May 23.

6.
7.

Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.

Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW.

Am J Surg Pathol. 2007 Jun;31(6):957-60.

PMID:
17527087
8.

The evolution of collagen expression in sarcomatoid renal cell carcinoma.

Delahunt B, Bethwaite PB, McCredie MR, Nacey JN.

Hum Pathol. 2007 Sep;38(9):1372-7. Epub 2007 May 22.

PMID:
17521699
9.

Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.

Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B.

Am J Surg Pathol. 2006 Sep;30(9):1091-6.

PMID:
16931953
10.

Malignant mixed Müllerian tumour of the cervix treated with concurrent chemoradiation.

Gastrell FH, Brasch HD, Johnson CA, Bethwaite PB, McConnell DT.

Aust N Z J Obstet Gynaecol. 2001 Aug;41(3):352-4.

PMID:
11592561
11.

Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.

Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM.

Hum Pathol. 2001 Jun;32(6):590-5.

PMID:
11431713
12.

Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour.

Delahunt B, Eble JN, King D, Bethwaite PB, Nacey JN, Thornton A.

Histopathology. 2000 Feb;36(2):109-15.

PMID:
10672054
13.

Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma.

Delahunt B, Bethwaite PB, Thornton A.

Br J Urol. 1997 Sep;80(3):401-4.

PMID:
9313657
14.

Polyclonal Ki-67 expression in transitional cell carcinoma of the bladder.

Jones HL, Delahunt B, Bethwaite PB, Thornton A.

Pathology. 1997 Feb;29(1):84-7.

PMID:
9094186
15.

Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.

Jones HL, Delahunt B, Bethwaite PB, Thornton A.

Anticancer Res. 1997 Jan-Feb;17(1B):685-7.

PMID:
9066602
16.

Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study.

Bethwaite PB, Holloway LJ, Thornton A, Delahunt B.

Pathology. 1996 Nov;28(4):321-7.

PMID:
9007950
17.

Diffuse malignant mesothelioma arising in a paracolostomy hernial sac.

Bethwaite PB, Evans R, Naik DK, Delahunt B, Teague CA.

Histopathology. 1996 Sep;29(3):282-4. No abstract available.

PMID:
8884360
18.
19.
20.

Occupational risk for renal cell carcinoma. A case-control study based on the New Zealand Cancer Registry.

Delahunt B, Bethwaite PB, Nacey JN.

Br J Urol. 1995 May;75(5):578-82.

PMID:
7613791

Supplemental Content

Loading ...
Support Center